Madrigal Pharmaceuticals market cap MDGL

Share price times shares outstanding: what the whole company sells for, since 2011.

Madrigal Pharmaceuticals is worth $10B at the close on Oct 23, 2026, at $434.24 a share.

That is up 7% over the last year and up 677% over five years.

Its highest close in our data was $13.6B in Dec 2025.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$10B	$9.9B	$13.5B	−26%
2025	$13.6B	$5.9B	$13.6B	+99%
2024	$6.8B	$3.7B	$7.6B	+49%
2023	$4.6B	$2.2B	$5.7B	−8%
2022	$5B	$964.1M	$5B	+243%
2021	$1.4B	$1.2B	$2.2B	−16%
2020	$1.7B	$927.8M	$2B	+20%
2019	$1.4B	$1.3B	$2.2B	−11%
2018	$1.6B	$1.2B	$4.3B	+40%
2017	$1.1B	$169.4M	$1.2B	+565%
2016	$172.4M	$26.2M	$191.1M	+257%
2015	$48.2M	$42.7M	$330.7M	−83%
2014	$284.2M	$284.2M	$445.7M	−17%
2013	$340.7M	$275.2M	$709.4M	−38%
2012	$550.3M	$213.8M	$590M	+138%
2011	$231.2M	$152.4M	$240.6M	n/a

Companies in Drug Manufacturers - General nearest Madrigal Pharmaceuticals' size, closest first, today.

Company	Market cap
MDGLMadrigal Pharmaceuticals	$10B
BMRNBiomarin Pharmaceutical	$10.8B
CORTCorcept Therapeutics	$9.3B
PTGXProtagonist Therapeutics	$9B
TGTXTG Therapeutics	$8.3B
ALKSAlkermes plc.	$7.3B
JAZZJazz Pharmaceuticals	$13.9B
AMRXAmneal Pharmaceuticals	$6.5B
LGNDLigand Pharmaceuticals	$6.1B
KNSAKiniksa Pharmaceuticals International	$6B
INDVIndivior Pharmaceuticals	$4.1B
Peer median	$7.8B